Hartmann A - Search Results

1

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Schüpbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltête D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y. Schüpbach WM, et al. Among authors: hartmann a. J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1640-4. doi: 10.1136/jnnp.2005.063206. J Neurol Neurosurg Psychiatry. 2005. PMID: 16291886 Free PMC article.

2

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debré P, Agid Y, Dugas B, Hirsch EC. Hunot S, et al. Among authors: hartmann a. J Neurosci. 1999 May 1;19(9):3440-7. doi: 10.1523/JNEUROSCI.19-09-03440.1999. J Neurosci. 1999. PMID: 10212304 Free PMC article.

3

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI, Agid Y, Hirsch EC. Hartmann A, et al. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2875-80. doi: 10.1073/pnas.040556597. Proc Natl Acad Sci U S A. 2000. PMID: 10688892 Free PMC article.

4

Mechanism of cell death in experimental models of Parkinson's disease.

Hirsch EC, Hunot S, Hartmann A. Hirsch EC, et al. Among authors: hartmann a. Funct Neurol. 2000 Oct-Dec;15(4):229-37. Funct Neurol. 2000. PMID: 11213526 No abstract available.

5

Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes.

Zarate-Lagunes M, Gu WJ, Blanchard V, Francois C, Muriel MP, Mouatt-Prigent A, Bonici B, Parent A, Hartmann A, Yelnik J, Boehme GA, Pradier L, Moussaoui S, Faucheux B, Raisman-Vozari R, Agid Y, Brice A, Hirsch EC. Zarate-Lagunes M, et al. Among authors: hartmann a. J Comp Neurol. 2001 Apr 2;432(2):184-96. doi: 10.1002/cne.1096. J Comp Neurol. 2001. PMID: 11241385

6

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC. Hartmann A, et al. J Neurochem. 2001 Mar;76(6):1785-93. doi: 10.1046/j.1471-4159.2001.00160.x. J Neurochem. 2001. PMID: 11259496 Free article.

7

Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.

Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC. Hartmann A, et al. J Neurosci. 2001 Apr 1;21(7):2247-55. doi: 10.1523/JNEUROSCI.21-07-02247.2001. J Neurosci. 2001. PMID: 11264300 Free PMC article.

8

Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.

Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC. Turmel H, et al. Among authors: hartmann a. Mov Disord. 2001 Mar;16(2):185-9. doi: 10.1002/mds.1037. Mov Disord. 2001. PMID: 11295768

9

Parkinson's disease. The apoptosis hypothesis revisited.

Hartmann A, Hirsch EC. Hartmann A, et al. Adv Neurol. 2001;86:143-53. Adv Neurol. 2001. PMID: 11553972 Review. No abstract available.

10

FADD: A link between TNF family receptors and caspases in Parkinson's disease.

Hartmann A, Mouatt-Prigent A, Faucheux BA, Agid Y, Hirsch EC. Hartmann A, et al. Neurology. 2002 Jan 22;58(2):308-10. doi: 10.1212/wnl.58.2.308. Neurology. 2002. PMID: 11805265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,455 results

Search Page

Filters